Loading patent…
AssigneeYaizu Suisankagaku Industry Co., Ltd.
InventorsYoshiharu Matahira, Kazuaki Kikuchi
Estimating the term…
An antifatigue composition for reducing muscular fatigue or the like during or after exercise, which includes an imidazole compound obtained from extracts of fishes, shelifishes, fowl, flesh or the like, as an active ingredient. The imidazole compound in the antifatigue composition is preferably at least one compound selected from the group consisting of histidine, anserine, carnosine, valenine and salts thereof. The antifatigue composition preferably further contains D-ribose as an active ingredient. By orally ingesting the antifatigue composition, the amount of lactic acid in plasma during or after exercise can be kept low, and therefore muscle fatigue caused by exercise can be controlled, and as a result, the ability to exercise can be improved.
A muscular fatigue-controlling composition consisting essentially of muscular fatigue-controlling synergistic effective amounts of (a) an imidazole compound which is anserine or a salt thereof and (b) D-ribose.
A muscular fatigue-controlling composition consisting essentially of (i) muscular fatigue-controlling synergistic effective amounts of (a) an imidazole compound which is anserine or a salt thereof and (b) D-ribose, and (ii) at least one substance selected from the group consisting of taurine, creatine, vitamin E, vitamin C, carotenoid, reduced glutathione and a mineral selected from the group consisting of calcium, sodium, magnesium, selenium, iron and zinc.
A method for providing a muscular fatigue-controlling effect comprising orally administering to a person in need thereof a muscular fatigue-controlling composition consisting essentially of synergistic effective amounts of (a) an imidazole compound which is anserine or a salt thereof and (b) D-ribose.
A method for providing a muscular fatigue-controlling effect comprising orally administering to a person in need thereof a muscular fatigue-controlling composition consisting essentially of (i) muscular synergistic fatigue-controlling effective amounts of (a) an imidazole compound which is anserine or a salt thereof and (b) D-ribose, and (ii) at least one substance selected from the group consisting of taurine, creatine, vitamin E, vitamin C, carotenoid, reduced glutathione and a mineral selected from the group consisting of calcium, sodium, magnesium, selenium, iron and zinc.
Dependencies are inferred from the claim text.